Rural health system Reid Health is using Abridge’s AI-powered documentation tech to reduce burnout among nurses. It appears to be working — after-shift charting is down by up to 45 minutes, and the RN vacancy rate has been cut more than in half, said Misti Foust-Cofield, Reid’s chief nursing officer. The post Documentation Tools Aren’t Just for Doctors: Inside Reid Health’s Deployment of Abridge’s Nurse Tech appeared first on MedCity News .
AI built on transparent, causal reasoning, systems that ground every output in validated biological mechanisms, show the pathway behind each recommendation, and cite their sources is what makes the difference between a tool that erodes clinical trust and one that rebuilds it. The post Why Generative AI Isn’t Enough: The Case for Causal Reasoning in Medicine appeared first on MedCity News .
It’s not low effort or underinvestment. It’s the steady-state output of an organization succeeding at the wrong thing. The post The Hidden Cost of “Good Enough” in Healthcare Experiences appeared first on MedCity News .
They are vast, deep, and nearly impossible to navigate without the right clinical lens applied on top. The real challenge facing health data platform companies and health system data teams is what to do with all of it. The post Have Healthcare Data Lakes Become “Data Swamps”? appeared first on MedCity News .
Counting hospital closures only tells part of the story, noted Duane Fitch, partner at Plante Moran. Across the country, hundreds of hospitals remain technically open while steadily shedding services their communities depend on, such as emergency care, obstetrics and psychiatric care. The post Why ‘Still Open’ Is the Wrong Way to Measure the Hospital Crisis appeared first on MedCity News .
Ionis Pharmaceuticals’ Tryngolza is now the first approved therapy for treating severe hypertriglyceridemia, a prevalent chronic metabolic disorder that can lead to acute pancreatitis. This drug is a key piece of Ionis’s pivot away from partnering its assets, and instead developing and commercializing them on its own. The post A Metabolic Disease Posing Severe Pancreatic Risks Gets Its First FDA-Approved Therapy appeared first on MedCity News .
Upside’s $20 million raise was led by Aquiline and Flare Capital Partners, with support from existing investors including 645 Ventures, Freestyle Capital, Triple Impact Capital and Techstars. The post Upside Seeks to Solve the Housing Crisis Armed with $20M Raise appeared first on MedCity News .
UnitedHealthcare CEO Tim Noel, Optum CEO Dr. Patrick Conway, and other top executives and employees gave unprecedented access to journalists and others in order to show how the company is trying to reduce friction in healthcare. The goal was to change hearts and minds. Did the insurance behemoth succeed? The post UnitedHealthcare Threw Open Its HQ to Journalists and Influencers. Why? appeared first on MedCity News .
Muhsin discussed how BD is rolling out a new medication dispenser and a software platform that pulls together data from the company’s various devices.
The MIT spinout will use the financing, from investors and the European Investment Bank, to accelerate the U.S. launch of its Coaptium sutureless nerve repair technology.
AI isn’t failing because it lacks capability. It’s failing because it isn’t consistently reaching the moments where decisions are made. The post Why Most Healthcare AI Fails After the Pilot Phase appeared first on MedCity News .
When education is incomplete, patients don’t just feel uninformed; they feel dismissed. The post Where Patient Education Breaks Down in Breast Cancer Care appeared first on MedCity News .
Gilead Sciences antibody drug conjugate Trodelvy is now approved as a first-line treatment for triple-negative breast cancer. This expanded approval for Trodelvy comes with a slightly broader label that gives it an edge over the AstraZeneca and Daiichi Sankyo ADC Datroway. The post New FDA Nod Keeps Gilead Drug Competitive With AstraZeneca & Daiichi in Breast Cancer appeared first on MedCity News .
Women’s health platform Xella Health launched with a $499-per-year membership. The platform provides women the kind of connected healthcare that has typically only been available through expensive concierge medicine, said CEO Kelly Lacob. The post Xella Health Emerges from Stealth to Give Women Answers the Healthcare System Hasn’t appeared first on MedCity News .
AI adoption in healthcare isn’t being led by innovation teams, it’s the clinicians The post Keeping Up With Clinicians appeared first on MedCity News .
The issue is not only functional. It is experiential. Many women do not need more scores. They need continuity, context, and support that feels companionable rather than corrective. The post Women’s Health Is Not a Wearable Feature — It’s an Operating System Problem appeared first on MedCity News .
Digital health solutions are booming, but a critical roadblock stands in the way: the lack of a common quality framework. Purchasers seek greater transparency from vendors regarding how their solutions engage members and improve health outcomes, while vendors need better data on the members they serve to provide more effective support. NCQA is launching a […] The post NCQA Launches Digital Health Engagement Accreditation Program appeared first on NCQA .